Gene therapy: Precision BioSciences
Precision BioSciences is focused on applying the proprietary ARCUS genome editing technology to cure genetic and infectious diseases where no adequate treatments exist. Gene editing technology has the incredible power to permanently cure devastating diseases; however, because gene edits are permanent, the risk of off-target or off-tissue gene edits can present a significant safety challenge.
Unlike some gene editing technologies that were designed primarily as research tools and subsequently engineered for therapeutic use, ARCUS was designed with therapeutic safety, delivery and control in mind.
Precision BioSciences has developed a robust pipeline of gene correction therapy candidates with a focus on diseases that have a clearly established genetic cause.
LEARN MORE: Precision Biosciences
Mitral valve disease
We are developing a novel cardio-protective gene therapy to stop the progression of heart failure in dogs. As a part of the technical development, we have launched a study in dogs with Mitral Valve Disease (MVD). This study will provide valuable information that will aid our effort to address MVD.
MORE INFO: Rejuvenate Bio